Emergence of NOTCH2-NTRK1 After Osimertinib in a Patient With Lung Adenocarcinoma With Neuroendocrine Differentiation
- 14 October 2020
- journal article
- abstracts
- Published by Elsevier BV in Journal of Thoracic Oncology
- Vol. 22 (2), e157-e159
- https://doi.org/10.1016/j.cllc.2020.10.003
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (81770024)
This publication has 3 references indexed in Scilit:
- The Evolving Landscape of Resistance to OsimertinibJournal of Thoracic Oncology, 2020
- NTRK fusion-positive cancers and TRK inhibitor therapyNature Reviews Clinical Oncology, 2018
- Efficacy of Larotrectinib inTRKFusion–Positive Cancers in Adults and ChildrenThe New England Journal of Medicine, 2018